Mutual Fund Details

Tata India Pharma & HealthCare Fund Direct-Growth

Name: Tata India Pharma & HealthCare Fund Direct-Growth
Brand: Tata Mutual Fund

Equity Pharma

NAV

₹30.1202

as on 02 Jul 2024, 11:14 PM

₹0.0282(0.09%)

Last Change

Scheme Ratings

rated by Value Research

Pharma

Rankings based on | as on Invalid date

Schemes Managed By

Meeta Shetty

Investment Performance

would have given a return of

₹1,10,871

₹1,21,647

₹1,51,834

₹1,58,809

Bank Account

Fixed Deposit

Regular Mutual Fund

This Fund on Paytm Money

This Mutual Fund

₹58,809

Profit (absolute return)

58.81%

in the last

max

+1% Higher Returns

With Direct Plans on Paytm Money

Investment Returns

In the last 3 months

4.08%

In the last 6 months

16.62%

In the last 1 year

45.52%

In the last 3 years

58.81%

In the last 5 years

222.74%

In the last 10 years

Absolute Returns

CAGR

Scheme Riskometer

low

low to moderate

moderate

moderately high

high

very high

Investors understand that their principal will be at very high risk

Scheme Information

Tata India Pharma & HealthCare Fund Direct-Growth

as of 31 May 2024, 05:30 AM

₹899.17 Cr

Scheme Asset Size

Fund Type

Open-End

Exit Load

Exit load of 0.25% if redeemed within 30 days.

0.79%

Expense Ratio

Plan

Growth

3.05%

Cash Holding

Benchmark

NIFTY Pharma Total Return Index

Scheme Document

View

Benchmark

NIFTY Pharma Total Return Index

Exit Load

Exit load of 0.25% if redeemed within 30 days.

Scheme Document

View

Companies Holding in this Mutual Fund

as on 31 May 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

13.06%

₹117.43 Cr

Aurobindo Pharma Ltd.

9.77%

₹87.85 Cr

Lupin Ltd.

8.98%

₹80.75 Cr

Dr. Reddy's Laboratories Ltd.

6.93%

₹62.31 Cr

Cipla Ltd.

6.68%

₹60.06 Cr

Others

54.58%

₹490.77 Cr

View All

Companies Holding in this Mutual Fund

as on 31 May 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

13.06%

₹117.43 Cr

Aurobindo Pharma Ltd.

9.77%

₹87.85 Cr

Lupin Ltd.

8.98%

₹80.75 Cr

Dr. Reddy's Laboratories Ltd.

6.93%

₹62.31 Cr

Cipla Ltd.

6.68%

₹60.06 Cr

Others

54.58%

₹490.77 Cr

View All

Funds in this Category

This fund's returns:

16.65%

Return Duration

3 Years

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

DSP Healthcare Fund Direct - Growth

SBI Healthcare Opportunities Fund Direct Plan-Growth

About Tata India Pharma & HealthCare Fund Direct-Growth

Tata India Pharma & HealthCare Fund Direct-Growth is a Equity mutual fund scheme from Tata Mutual Fund. This scheme was launched on Invalid date and is currently managed by its fund manager Meeta Shetty. It has an AUM of ₹899.17 Crores and the latest NAV decalared is ₹30.120 as on 03 Jul 2024 at 7:22 pm.

Tata India Pharma & HealthCare Fund Direct-Growth scheme return performance in last 1 year is 45.52%, in last 3 years is 58.81% and 199.87% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.